Bioorganic & medicinal chemistry letters
Journal
Overview
publication venue for
-
Design and Biophysical Characterization of Second-Generation cyclic peptide LAG-3 inhibitors for cancer immunotherapy..
113.
2024
-
Stability studies of β-Amino- and β-Hydroxy difluoromethyl ketones in rat serum and rat liver microsomes.
2024
-
Design and synthesis of a library of C8-substituted sulfamidoadenosines to probe bacterial permeability..
110.
2024
-
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction.
2024
-
Design and Synthesis of a Library of C2-Substituted Sulfamidoadenosines to Probe Bacterial Permeability.
2023
-
Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9).
2022
-
Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships..
60.
2022
-
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics..
57.
2021
-
Discovery of biphenyl pyrazole scaffold for neurodegenerative diseases: A novel class of acetylcholinesterase-centered multitargeted ligands..
30.
2020
-
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells..
29.
2019
-
Quinoline and thiazolopyridine allosteric inhibitors of MALT1..
29.
2019
-
Peptide-based covalent inhibitors of MALT1 paracaspase..
29.
2019
-
A novel tetrazole analogue of resveratrol is a potent anticancer agent..
29.
2018
-
Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors..
28.
2018
-
Modular synthesis of new C-aryl-nucleosides and their anti-CML activity..
28.
2018
-
Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes..
26.
2016
-
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors..
26.
2016
-
Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis..
26.
2016
-
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity..
26.
2016
-
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones..
26.
2016
-
Cheminformatic comparison of approved drugs from natural product versus synthetic origins..
25.
2015
-
Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5)..
25.
2015
-
Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6)..
25.
2015
-
Potent benzoazepinone γ-secretase modulators with improved bioavailability..
25.
2015
-
Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3)..
25.
2015
-
Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4)..
25.
2015
-
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)..
25.
2015
-
Undesired versus designed enzymatic cleavage of linkers for liver targeting..
24.
2014
-
Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity..
24.
2013
-
Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin..
23.
2013
-
Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs..
23.
2012
-
Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain..
22.
2012
-
The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK)..
22.
2012
-
Cyclic amino acid linkers stabilizing key loops of brain derived neurotrophic factor..
22.
2011
-
Chemical scaffolds with structural similarities to siderophores of nonribosomal peptide-polyketide origin as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis..
21.
2011
-
Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy..
21.
2011
-
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture..
21.
2011
-
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase..
21.
2011
-
Identification of new inhibitors of protein kinase R guided by statistical modeling..
21.
2011
-
Triazoles as γ-secretase modulators..
21.
2011
-
A protecting group-free synthesis of deazathiamine: a step toward inhibitor design..
20.
2010
-
Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors..
20.
2010
-
2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability..
20.
2010
-
Purine derivatives as potent gamma-secretase modulators..
20.
2010
-
Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent..
20.
2010
-
Fluorinated piperidine acetic acids as gamma-secretase modulators..
20.
2009
-
Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability..
19.
2009
-
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors..
19.
2009
-
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists..
20.
2009
-
Design, syntheses, and evaluation of Taspase1 inhibitors..
19.
2009
-
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1)..
19.
2009
-
An efficient chemical approach to bispecific antibodies and antibodies of high valency..
19.
2009
-
Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides..
19.
2009
-
Multiple catalytic aldolase antibodies suitable for chemical programming..
19.
2009
-
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization..
19.
2008
-
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)..
18.
2008
-
Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis..
18.
2008
-
Highly functionalized 7-azaindoles as selective PPAR gamma modulators..
18.
2008
-
Design of a fluorescence polarization assay platform for the study of human Hsp70..
18.
2008
-
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)..
18.
2008
-
A series of novel, potent, and selective histone deacetylase inhibitors..
16.
2006
-
Synthesis of a red-shifted fluorescence polarization probe for Hsp90..
16.
2006
-
Design and synthesis of potent and subtype-selective PPARalpha agonists..
16.
2005
-
Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists..
15.
2005
-
Synthesis and evaluation of photolabile insulin prodrugs..
15.
2005
-
Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain..
15.
2005
-
Selective PPARgamma modulators with improved pharmacological profiles..
15.
2005
-
DNA photocleavage and biological activity of a pyrene dihydrodioxin..
15.
2005
-
Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain..
15.
2005
-
Thiourea inhibitors of herpesviruses. Part 3: Inhibitors of varicella zoster virus..
14.
2004
-
Thiourea inhibitors of herpes viruses. Part 2: N-Benzyl-N'-arylthiourea inhibitors of CMV..
14.
2004
-
Synthesis and antitumor evaluation of benzoylphenylurea analogs..
14.
2004
-
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90..
13.
2003
-
Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties..
13.
2003
-
Thiourea inhibitors of herpes viruses. Part 1: bis-(aryl)thiourea inhibitors of CMV..
13.
2003
-
Nodulisporic acid side-chain modifications: access to the 2", 3", 4", and 6" registers..
13.
2003
-
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter..
12.
2002
-
Side-chain homologation of nodulisporic acid: synthesis of potent new dienyl derivatives..
12.
2002
-
Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor..
12.
2002
-
Fluorescent monitoring of kinase activity in real time: development of a robust fluorescence-based assay for Abl tyrosine kinase activity..
11.
2001
-
LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family..
11.
2001
-
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 1..
11.
2001
-
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 2..
11.
2001
-
Chemical modification of nodulisporic acid A: preliminary structure-activity relationships..
10.
2000
-
Synthesis and evaluation of geldanamycin-testosterone hybrids..
10.
2000
-
Synthesis and evaluation of geldanamycin-estradiol hybrids..
9.
1999
-
Synthesis of gem-difluoro-avermectin derivatives: potent anthelmintic and anticonvulsant agents..
8.
1998
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)